Express Scripts (ESRX) Says Anthem (ANTM) Intends to Move its Business
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/7/2026
Go back to Express Scripts (ESRX) Says Anthem (ANTM) Intends to Move its Business
April 25, 2017 12:43 PM EDT
Evercore ISI lowered its price target on Express Scripts (NASDAQ: ESRX) to $59.00 (from $68.50) while maintaining a In Line rating.
Analyst Ross Muken commented, "Given the size / scope of the questions outstanding regarding ESRXs business model, we see valuation as... More
April 25, 2017 9:36 AM EDT
Morgan Stanley lowered its price target on Express Scripts (NASDAQ: ESRX) to $52.00 (from $71.00) while maintaining a Underweight rating, following news that Anthem intends move its PBM business from the company.
Analyst Ricky Goldwasser lowers estimates on the announcement, suggesting the competitive landscape could deteriorate,... More
April 24, 2017 5:26 PM EDT
Cantor Fitzgerald maintains Neutral rating and $165 price target on Anthem (NYSE: ANTM) as the company's pharmacy benefit manager, Express Scripts (ESRX), announced that it is unlikely that Anthem will renew its contract which expires on December 31, 2019.
Analyst Steven Halper notes the company generated... More
April 24, 2017 4:13 PM EDT
Express Scripts (NASDAQ: ESRX) to Resume Trading at 4:45 PM ET
...
More
April 24, 2017 4:02 PM EDT
Express Scripts (NASDAQ: ESRX) reported Q1 EPS of $1.33, $0.01 better than the analyst estimate of $1.32. Revenue for the quarter came in at $24.66 billion versus the consensus estimate of $24.99 billion.
Adjusted claims of 351.7 million, down 1% See Table 1GAAP net income of $546.3 million, up...
More
April 24, 2017 4:00 PM EDT
Express Scripts (NASDAQ: ESRX) Halted, News Pending
...
More
